Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Return on Capital Employed: 2014-2020

Historic Return on Capital Employed for Larimar Therapeutics (LRMR) over the last 5 years, with Mar 2020 value amounting to -1.21%.

  • Larimar Therapeutics' Return on Capital Employed fell 64.00% to -1.21% in Q1 2020 from the same period last year, while for Mar 2020 it was -1.21%, marking a year-over-year decrease of 64.00%. This contributed to the annual value of -0.79% for FY2019, which is 18.00% down from last year.
  • Per Larimar Therapeutics' latest filing, its Return on Capital Employed stood at -1.21% for Q1 2020, which was down 14.82% from -1.06% recorded in Q4 2019.
  • Larimar Therapeutics' 5-year Return on Capital Employed high stood at -0.46% for Q4 2016, and its period low was -1.21% during Q1 2020.
  • Its 3-year average for Return on Capital Employed is -0.73%, with a median of -0.63% in 2018.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first increased by 16bps in 2019, then tumbled by 64bps in 2020.
  • Larimar Therapeutics' Return on Capital Employed (Quarterly) stood at -0.46% in 2016, then decreased by 11bps to -0.57% in 2017, then climbed by 3bps to -0.54% in 2018, then plummeted by 52bps to -1.06% in 2019, then plummeted by 64bps to -1.21% in 2020.
  • Its Return on Capital Employed stands at -1.21% for Q1 2020, versus -1.06% for Q4 2019 and -0.65% for Q3 2019.